E-mail this story

Obesity drugs need heart studies, U.S. advisers say

SILVER SPRING, Maryland (Reuters) - Heart safety studies should be required for new obesity drugs, U.S. drug advisers said on Thursday, possibly adding a new hurdle to the drugs' approval.

Anna Yukhananov

March 29, 2012

Send to (as many as 3 e-mail addresses, separated by commas):

Send me a copy.

From:

200 characters remaining